AAPS PharmSci 360 Opening Session Explores How to Build a More Efficient Pipeline
FNIH CEO and Former CDC Director to Deliver Talk on October 25
Washington, DC—The 2026 PharmSci 360 conference opens with an in-depth look at the current drug development pipeline and how to make the process as a whole more efficient.
Julie Louise Gerberding, M.D., M.P.H., President and Chief Executive Officer of the Foundation for the National Institutes of Health (FNIH), delivers the event’s opening plenary on Sunday, Oct. 25. Her talk, titled “Adaptive Intelligence: Accelerating Biomedical Innovation,” focuses on the opportunity to integrate emerging approaches to product development, including novel alternative methods, AI, adaptive trial innovations, and other approaches to improve the efficiency and safety of translational medicine.
“Everyone wants faster drug development. The real challenge is not simply accelerating individual activities but redesigning the development paradigm itself,” AAPS 2026 PharmSci 360 Scientific Programming Committee Chair Parag Kolhe, Ph.D., said. “Dr. Gerberding will share a compelling vision for a more cyclical, parallel, and integrated approach that has the potential to compress timelines while preserving scientific rigor and quality.”
PharmSci 360 will take place Oct. 25-28, in New Orleans, LA, at the Ernest N. Morial Convention Center. To learn more and to register, visit http://www.aaps.org/pharmsci360.
American Association of Pharmaceutical Scientists (AAPS) is a 501(c)(3) non-profit association of more than 7,000 scientists and professionals employed in academia, industry, regulatory, and other research related to the pharmaceutical sciences worldwide. Its mission is to advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health, which members pursue through four peer-reviewed journals and a variety of events in person and online. www.aaps.org
AAPs PharmSci 360 delivers research from across the pharmaceutical continuum, from discovery to delivery, and all stages in between. Thousands of scientists from across the globe converge to discuss cutting-edge breakthroughs, technologies, and techniques in symposia and poster presentations at this science-first event. http://www.aaps.org/pharmsci360